When LS is assessed on the basis of personal and/or familial history of cancer, MSH2 and MLH1 germline lesions are found in the great majority of patients (up to 87%), with MSH6 and PMS2 germline defects only accounting for a minority of cases (Boland et al., 2018). Here, MSH2 is linked to cancer.